Intracellular mechanisms of TRAIL and its role in cancer therapy.
about
Genetically engineered Newcastle disease virus expressing interleukin-2 and TNF-related apoptosis-inducing ligand for cancer therapy.Resveratrol inhibits growth of orthotopic pancreatic tumors through activation of FOXO transcription factors.Inhibition of PI3K/AKT and MAPK/ERK pathways causes activation of FOXO transcription factor, leading to cell cycle arrest and apoptosis in pancreatic cancer.The dietary bioflavonoid quercetin synergizes with epigallocathechin gallate (EGCG) to inhibit prostate cancer stem cell characteristics, invasion, migration and epithelial-mesenchymal transition.TRAIL/Apo-2L: mechanisms and clinical applications in cancer.Ursolic acid, a pentacyclin triterpene, potentiates TRAIL-induced apoptosis through p53-independent up-regulation of death receptors: evidence for the role of reactive oxygen species and JNKDown-regulation of adenine nucleotide translocase 3 and its role in camptothecin-induced apoptosis in human hepatoma QGY7703 cells.Embelin suppresses growth of human pancreatic cancer xenografts, and pancreatic cancer cells isolated from KrasG12D mice by inhibiting Akt and Sonic hedgehog pathways.Induction of cellular prion protein (PrPc) under hypoxia inhibits apoptosis caused by TRAIL treatment.Sensitization of TRAIL-resistant LNCaP cells by resveratrol (3, 4', 5 tri-hydroxystilbene): molecular mechanisms and therapeutic potential.Curcumin enhances the apoptosis-inducing potential of TRAIL in prostate cancer cells: molecular mechanisms of apoptosis, migration and angiogenesis.(E)-2,4-bis(p-hydroxyphenyl)-2-butenal has an antiproliferative effect on NSCLC cells induced by p38 MAPK-mediated suppression of NF-κB and up-regulation of TNFRSF10B (DR5).β-Phenethyl isothiocyanate induces death receptor 5 to induce apoptosis in human oral cancer cells via p38.Smac/DIABLO enhances the therapeutic potential of chemotherapeutic drugs and irradiation, and sensitizes TRAIL-resistant breast cancer cells.Interactive effects of HDAC inhibitors and TRAIL on apoptosis are associated with changes in mitochondrial functions and expressions of cell cycle regulatory genes in multiple myeloma.Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs.Inhibitors of XIAP sensitize CD40-activated chronic lymphocytic leukemia cells to CD95-mediated apoptosis.Pro-survival function of Akt/protein kinase B in prostate cancer cells. Relationship with TRAIL resistance.Constitutively active Akt is an important regulator of TRAIL sensitivity in prostate cancer.Simvastatin inhibits the apoptosis of hippocampal cells in a mouse model of Alzheimer's disease.
P2860
Q34028464-C0B8B584-3149-47A1-B55A-D8C7E8A61821Q34042949-76C8C8D7-B842-41FB-9863-34625513C47FQ34043823-EE9E3D79-E00C-4CFB-A86B-8D27DFC89F8BQ34105402-13D0840E-84DE-46C6-BC67-8DA04AFEBFF1Q34482821-7F188266-51D3-4CD6-94FD-1FD1DA36240BQ34568521-219711EC-A7D5-4BEC-BC50-1834C2A507DAQ34911405-2C8E2256-21E4-4DDE-BF3C-D2257DF99093Q35138276-0D6E9975-6E0C-48D4-AAB3-4B97D9EECA50Q35741681-A6916E46-DA99-4D98-A6EA-744C2EF52780Q36059686-11A9961C-D29B-4D1C-863A-CD83A8E3564DQ36151210-72658F8E-DF71-4FD5-A95F-424F4B918E78Q36681789-B2B8ACA1-68BC-426D-8BED-0C3F02A063EDQ39400925-3F9AD79B-7703-4D26-906A-5D767EFD6193Q39966860-5CED2367-95F9-4F67-9924-669A7CEFDF53Q40396320-5DC3A2D5-730A-4403-B253-02B833039682Q40563380-FD476D3A-2D7E-4658-970C-26560AB148EBQ42089513-F8647F42-B174-46A2-A0B4-D746BD10F174Q43680908-98EE81E5-C35D-42DB-B5E6-A02527175EC5Q43761459-C72B1E5A-A006-4CBE-9128-4CBF2BA22258Q49747183-E86A9760-6C37-40E8-B528-77344BE6B5C5
P2860
Intracellular mechanisms of TRAIL and its role in cancer therapy.
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Intracellular mechanisms of TRAIL and its role in cancer therapy.
@ast
Intracellular mechanisms of TRAIL and its role in cancer therapy.
@en
Intracellular mechanisms of TRAIL and its role in cancer therapy.
@nl
type
label
Intracellular mechanisms of TRAIL and its role in cancer therapy.
@ast
Intracellular mechanisms of TRAIL and its role in cancer therapy.
@en
Intracellular mechanisms of TRAIL and its role in cancer therapy.
@nl
prefLabel
Intracellular mechanisms of TRAIL and its role in cancer therapy.
@ast
Intracellular mechanisms of TRAIL and its role in cancer therapy.
@en
Intracellular mechanisms of TRAIL and its role in cancer therapy.
@nl
P356
P1476
Intracellular mechanisms of TRAIL and its role in cancer therapy.
@en
P2093
Srivastava RK
P356
10.1006/MCBR.2001.0265
P577
2000-08-01T00:00:00Z